Lu et al., 1996 - Google Patents
Inhibition of prolactin receptor gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cellsLu et al., 1996
- Document ID
- 9303109410276622547
- Author
- Lu Y
- Sun G
- Wang X
- Safe S
- Publication year
- Publication venue
- Archives of biochemistry and biophysics
External Links
Snippet
Treatment of MCF-7 human breast cancer cells with 10 nM2, 3, 7, 8-tetrachlorodibenzo-p- dioxin (TCDD) did not decrease prolactin receptor (PRLR) binding. In contrast, PRLR mRNA levels were significantly decreased within 12 h after treatment with TCDD and persisted for …
- 102100018130 PRLR 0 title abstract description 98
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Santen et al. | Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity | |
Corcoran et al. | Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism∗ | |
Namer et al. | Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer | |
Planas-Silva et al. | Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer | |
Astroff et al. | Inhibition of the 17β-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus | |
Santen et al. | Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment | |
Lu et al. | Inhibition of prolactin receptor gene expression by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells | |
US5723291A (en) | Methods for screening compounds for estrogenic activity | |
Park et al. | RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries | |
Cormier et al. | Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth | |
Pascale et al. | Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydrocpiandrosterone in preneoplastic liver nodules | |
Sarkar et al. | Role of transforming growth factor (TGF)-β type I and TGF-β type II receptors in the TGF-β1-regulated gene expression in pituitary prolactin-secreting lactotropes | |
Tripathi et al. | Platelet activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells | |
AU682398B2 (en) | Methods for screening antiestrogen compounds | |
Varma et al. | Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling | |
US20060057628A1 (en) | Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof | |
Han et al. | Ethacrynic acid inhibits multiple steps in the NF-κB signaling pathway | |
BALASUBRAMANIAN et al. | Thapsigargin suppresses phorbol ester-dependent human involucrin promoter activity by suppressing CCAAT-enhancer-binding protein α (C/EBPα) DNA binding | |
Lee et al. | Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens | |
Dipippo et al. | Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat | |
Rabin et al. | Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production. | |
Hong et al. | Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells. | |
Ricci et al. | ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function | |
YAMASHITA et al. | Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells | |
Glantschnig et al. | The cellular protooncogenes c-fos and egr-1 are regulated by prostacyclin in rodent osteoblasts and fibroblasts |